then categorized as nonmetastatic CRPC. “A large number of these patients have no evidence of disease on nuclear scans; CT imaging of the chest, abdomen, and pelvis; or MRI, and become castration-resistant,” she said. Three randomized trials in
Search Results
Richard T. Hoppe
systems, and treatment verification. These advances have been facilitated by improvements in diagnostic imaging, including MRI and PET/CT. At first, these innovations were used for the treatment of solid tumors, wherein it became possible to further
Martin C. Mahoney
://www.survivorshipguidelines.org/ . Accessed July 19, 2007 . 11. Saslow D Boetes C Burke W . American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography . CA Cancer J Clin 2007 ; 57 : 75 – 89 . 12. Gail MH Brinton LA Byar DP
Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, Nicholas N. Nissen, and Jun Gong
, contrast-enhanced CT or MRI scan is sometimes used as a surveillance test in high-risk individuals. 8 The American Association for the Study of Liver Diseases (AASLD) endorsed an HCC surveillance program for high-risk patients with its first HCC practice
Ryan M. Kahn, Sushmita Gordhandas, Emeline Aviki, and Kara Long Roche
deny coverage for individuals at risk. Patients, physicians, and advocacy groups have identified breast MRI in carriers of HBOC and colonoscopies for younger individuals with Lynch syndrome as the most difficult services to obtain. 2 , 3 Difficulty in
Matthew Barth, Ana C. Xavier, Saro Armenian, Anthony N. Audino, Lindsay Blazin, David Bloom, Jong Chung, Kimberly Davies, Hilda Ding, James B. Ford, Paul J. Galardy, Rabi Hanna, Robert Hayashi, Cathy Lee-Miller, Andrea Judit Machnitz, Kelly W. Maloney, Lianna Marks, Paul L. Martin, David McCall, Martha Pacheco, Anne F. Reilly, Mikhail Roshal, Sophie Song, Joanna Weinstein, Sara Zarnegar-Lumley, Nicole McMillian, Ryan Schonfeld, and Hema Sundar
, and pelvis (see PBCL-3 , page 1270). FDG-PET/CT or FDG-PET/MRI is recommended if available. 25 However, treatment should not be delayed to obtain this scan, and FDG-PET does not exclude the need for full diagnostic quality, high-resolution CT or MRI
Gregory P. Kalemkerian, Billy W. Loo Jr, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Charles C. Williams Jr, Karin G. Hoffmann, and Miranda Hughes
fractionation schemes. The survival advantage of PCI was recently challenged by a randomized phase III Japanese trial of 224 patients with extensive-stage SCLC. 25 Patients were required to have an MRI before PCI to confirm the absence of brain metastases and
Antonio Di Meglio, Nancy U. Lin, Rachel A. Freedman, William T. Barry, Eric P. Winer, and Ines Vaz-Luis
day 1 of first-line treatment. Specifically, we examined (1) imaging modality used (chest/abdomen/pelvis CT, bone scan, 18 F-fluorodeoxyglucose [FDG]-PET/PET-CT, abdominal MRI, abdominal ultrasound, chest radiograph, spine MRI, head CT, brain MRI); (2
Ralph Hauke
Roentgenol 1988 ; 151 : 497 – 501 . 16. Choyke PL . Detection and staging of renal cancer . Magn Reson Imaging Clin N Am 1997 ; 5 : 29 – 47 . 17. Janus CL Mendelson DS . Comparison of MRI and CT for study of renal and perirenal
Harold J. Burstein
matter of days or a few weeks before death. In my hospital network, hospitalization functions as a complicated catalyst for these transitions. Urgent testing, including diagnostic laboratory studies or CT and MRI scans, is more readily available at any